Two Pharmaceutical Companies Agree to Pay a Total of Nearly $125 Million to Resolve Allegations That They Paid Kickbacks Through Copay Assistance Foundations
The Department of Justice announced today that two more pharmaceutical companies - Astellas Pharma US Inc. (Astellas) and Amgen Inc. (Amgen) - have agreed to pay a total of $124.75 million to resolve allegations that they each violated the False Claims Act by illegally paying the Medicare copays for their own products, through purportedly independent foundations that the companies used as mere conduits.
- Date:April 25, 2019
- Agency:U.S. Department of Justice
- Criminal and Civil Actions